Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents
Ragnar Hanas,
Johnny Ludvigsson,
Corresponding Author
Ragnar Hanas
Department of Pediatrics, Uddevalla Hospital; and
*Ragnar Hanas, Uddevalla Hospital, S-451 80 Uddevalla, Sweden. Tel: +46-522-92000; fax: + 46-522-93149; e-mail: [email protected]Search for more papers by this authorJohnny Ludvigsson
Division of Pediatrics and Diabetes Research Center, Linköping University Hospital, Sweden
Search for more papers by this authorRagnar Hanas,
Johnny Ludvigsson,
Corresponding Author
Ragnar Hanas
Department of Pediatrics, Uddevalla Hospital; and
*Ragnar Hanas, Uddevalla Hospital, S-451 80 Uddevalla, Sweden. Tel: +46-522-92000; fax: + 46-522-93149; e-mail: [email protected]Search for more papers by this authorJohnny Ludvigsson
Division of Pediatrics and Diabetes Research Center, Linköping University Hospital, Sweden
Search for more papers by this authorAbstract
Abstract: This review deals with the two most serious side effects encountered with insulin pump therapy, severe hypoglycemia and diabetic ketoacidosis (DKA). Although clinical follow-up studies reported decreased rates of severe hypoglycemia, randomized studies have not confirmed this, showing no difference between the pump and injection groups. Less-severe hypoglycemia (mild/moderate/symptomatic hypoglycemia) was found to be more common with pump use. Some patients have inadvertently dosed or overdosed while awake or during sleep, causing fatal outcome in rare cases. Population-based or retrospective clinical studies reported a low rate of DKA in pump users that was still a higher rate than those using injection therapy, at least in some countries. In research settings and for patients with good compliance and adequate family support, the risk of DKA seems lower; many short-term studies report no DKA at all, possibly due to the increased attention given to participants. The use of continuous subcutaneous insulin infusion (CSII) seems to decrease the risk in patients who had recurrent DKA before pump start. Most episodes of DKA occur early after pump start, suggesting a learning curve occurs in all new forms of treatment. Increased teaching and awareness programs are vital to prevent severe hypoglycemia and DKA in children and adolescents using insulin pumps.
References
- 1 DCCT TRG. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group (see comments). N Engl J Med 1993: 7: 977–986.
- 2 Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus[published erratum appears in N Engl J Med 1994 February 24; 330(8): 584]. N Engl J Med 1994: 330: 15–18.
- 3 Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes-the Linkoping Diabetes Complications Study. Diabetologia 2004: 47: 1266–1272.
- 4
Egger M,
Davey Smith G,
Stettler C,
Diem P.
Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis.
Diabet Med
1997: 14: 919–928.
10.1002/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- 5 Nordfeldt S, Ludvigsson J. Adverse events in intensively treated children and adolescents with type 1 diabetes. Acta Paediatr 1999: 88: 1184–1193.
- 6 Norgaard K. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark. Diabet Med 2003: 20: 307–311.
- 7 Knight G, Boulton AJ, Drury J et al. A feasibility study of the use of continuous subcutaneous insulin infusion in a diabetic clinic: patients' choice of treatment. Diabet Med 1984: 1: 267–272.
- 8 Brink SJ, Stewart C. Insulin pump treatment in insulin-dependent diabetes mellitus. Children, adolescents, and young adults. JAMA 1986: 255: 617–621.
- 9 Mecklenburg RS, Benson EA, Benson JW Jr et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984: 252: 3265–3269.
- 10 Teutsch SM, Herman WH, Dwyer DM, Lane JM. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med 1984: 310: 361–368.
- 11 Steel J. Intrauterine death of baby because of incorrect pump use. Br Med J (Clin Res Ed) 1985: 290: 1787.
- 12 Ludvigsson J, Nordfeldt S. Hypoglycaemia during intensified insulin therapy of children and adolescents. J Pediatr Endocrinol Metab 1998: 11 (Suppl. 1): 159–166.
- 13 Ludvigsson J, Bolli GB. Intensive insulin treatment in diabetic children. Diabetes Nutr Metab 2001: 14: 292–304.
- 14 Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004: 114: e91–e95.
- 15 Raile K, Noelle V, Landgraf R, Schwarz HP. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion (CSII) therapy. J Pediatr Endocrinol Metab 2002: 15: 607–612.
- 16 Levy-Marchal C, Czernichow P. Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. Diabete Metab 1988: 14: 108–113.
- 17 Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes (see comments). Diabetes Care 1999: 22: 1779–1784.
- 18 Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001: 107: 351–356.
- 19 Weinzimer SA, Ahern JH, Doyle EA et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004: 114: 1601–1605.
- 20 Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003: 143: 796–801.
- 21 Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes 2005: 6: 17–21.
- 22 De Beaufort CE, Houtzagers CM et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989: 6: 766–771.
- 23 Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005: 28: 15–19.
- 24 Dimeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380–384.
- 25 Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005: 28: 1277–1281.
- 26 Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003: 112 (Part 1): 559–564.
- 27 Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003: 26: 1079–1087.
- 28 Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004: 8: iii, 1–171.
- 29 Ludvigsson J. [Insulin infusion pump – an alternative to conventional insulin treatment in juvenile diabetes]. Lakartidningen 1982: 79: 1573–1575.
- 30 Hildebrandt P, Birch K. Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow. Diabet Med 1988: 5: 434–440.
- 31 Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998: 21: 817–821.
- 32 Reichel A, Rietzsch H, Kohler HJ, Pfutzner A, Gudat U, Schulze J. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes 1998: 106: 168–172.
- 33 Guerci B, Benichou M, Floriot M et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003: 26: 1137–1141.
- 34 Marcus AO, Fernandez MP. Insulin pump therapy: acceptable alternative to injection therapy. Postgrad Med 1996: 99: 125–132, 42–44.
- 35 Ham MR, Okada P, White PC. Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. Pediatr Diabetes 2004: 5: 39–43.
- 36 Haymond MW, Karl IE, Clarke WL, Pagliara AS, Santiago JV. Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children. Metabolism 1982: 31: 33–42.
- 37 Brambilla P, Artavia-Loria E, Chaussain JL, Bougneres PF. Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children. Diabetes Care 1987: 10: 44–48.
- 38 Laffel L, Loughlin C, Tovar A, Zuehlke J, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 2006: 23 (3): 278–84.
- 39 Laffel L. Sick-day management in type 1 diabetes. Endocrinol Metab Clin North Am 2000: 29: 707–723.
- 40 Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes[published erratum appears in Diabetes Care 1997 July; 20 (7): 1216]. Diabetes Care 1997: 20: 714–720.
- 41 Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit (see comments). Lancet 1997: 350: 1505–1510.
- 42 Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995: 27: 199–204.
- 43 Blackett PR. Insulin pump treatment for recurrent ketoacidosis in adolescence (letter). Diabetes Care 1995: 18: 881–882.
- 44 Adamsson U, Forsander G, Attvall S. Clinical consensus guidelines for insulin pump treatment in adults, children and adolescents. DiabetologNytt 2005: 18: 11–13.
- 45 Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF et al. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 1986: 293: 1195–1199.
- 46 Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996: 19: 324–327.
- 47 Tubiana-Rufi N, De Lonlay P, Bloch J, Czernichow P. [Remission of severe hypoglycemic incidents in young diabetic children treated with subcutaneous infusion]. Arch Pediatr 1996: 3: 969–976.
- 48 Danne T, Battelino T, Jarosz-Chobot P et al. The PedPump Study: a low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005: 54 (Suppl. 1): A453 (Abstract).
- 49 Hanas R, Lindblad B, Lindgren F. A 2-year population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Diabetes 2005: 54 (Suppl. 1): A455 (Abstract).
- 50 Minutti C, Thurlow B, Zimmerman D. Insulin pumps on pediatric patients: the Mayo Clinic experience. Diabetes Res Clin Pract 2000: 50 (Suppl. 1): S201 (Abstract).
- 51 Williams LB, Storch EA, Lewin AB, Geffken GR, Silverstein JH. Selecting families for successful insulin pump therapy. J Pediatr 2005: 146: 713–714 (Author reply).
- 52 Hanas R. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Horm Res 2002: 57 (Suppl. 1): 101–104.
- 53 Bougneres PD, Landier F, Lemmel C, Mensire A, Chaussain JL. Insulin pump therapy in young children with type 1 diabetes. J Pediatr 1984: 105: 212–217.
- 54
Kaufman FR,
Halvorson M,
Carpenter S,
Devoe D,
Pitukcheewanont P.
Insulin pump therapy in young children with diabetes.
Diabetes Spectrum
2001: 14: 84–89.
10.2337/diaspect.14.2.84 Google Scholar
- 55 Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr 2002: 140: 235–240.
- 56 Rami B, Nachbaur E, Waldhoer T, Schober E. Continuous subcutaneous insulin infusion in toddlers. Eur J Pediatr 2003: 162: 721–722.
- 57 Sulli N, Shashaj B. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003: 16: 393–399.
- 58 Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003: 26 (4): 1142–6.
- 59 Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554–1558.
- 60 Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 223–226.
- 61 Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006: 7: 25–31.
- 62 Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr 1998: 87: 537–541.
- 63 Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001: 139 (2): 197–203.
- 64 Rewers A, Chase HP, Mackenzie T et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 276: 2511–2518.
